{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:55:14Z","timestamp":1787237714963,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":1234,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81521062; 81630098"],"award-info":[{"award-number":["81521062; 81630098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2019FZA7016"],"award-info":[{"award-number":["2019FZA7016"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s13311-019-00815-3","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T15:02:35Z","timestamp":1575471755000},"page":"710-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window"],"prefix":"10.1016","volume":"17","author":[{"given":"Junli","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenglin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4755-9357","authenticated-orcid":false,"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1007\/s13311-019-00815-3_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-019-00815-3_bib2","doi-asserted-by":"crossref","unstructured":"Seinfeld, S., H.P. Goodkin, and S. Shinnar, Status Epilepticus. Cold Spring Harbor Perspectives in Medicine, 2016. 6(3).","DOI":"10.1101\/cshperspect.a022830"},{"key":"10.1007\/s13311-019-00815-3_bib3","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"issue":"2","key":"10.1007\/s13311-019-00815-3_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WCO.0b013e3283446f31","article-title":"The treatment of status epilepticus","volume":"24","author":"Shorvon","year":"2011","journal-title":"Current Opinion in Neurology"},{"key":"10.1007\/s13311-019-00815-3_bib5","doi-asserted-by":"crossref","unstructured":"Verrotti, A. and C. Mazzocchetti, Timely treatment of refractory convulsive status epilepticus. Nature Reviews Neurology, 2018. 14(5): p. 256- + .","DOI":"10.1038\/nrneurol.2018.38"},{"issue":"10","key":"10.1007\/s13311-019-00815-3_bib6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"3","key":"10.1007\/s13311-019-00815-3_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol"},{"issue":"Suppl 9","key":"10.1007\/s13311-019-00815-3_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1528-1167.2008.01928.x","article-title":"Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs","volume":"49","author":"Wasterlain","year":"2008","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-019-00815-3_bib9","doi-asserted-by":"crossref","unstructured":"Wilkes, R. and R.C. Tasker, Pediatric Intensive Care Treatment of Uncontrolled Status Epilepticus. Critical Care Clinics, 2013. 29(2): p. 239- + .","DOI":"10.1016\/j.ccc.2012.11.007"},{"issue":"1","key":"10.1007\/s13311-019-00815-3_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the Evaluation and Management of Status Epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocritical Care"},{"issue":"4","key":"10.1007\/s13311-019-00815-3_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/ane.12898","article-title":"Cognitive dysfunction after generalized tonic-clonic status epilepticus in adults","volume":"137","author":"Power","year":"2018","journal-title":"Acta Neurologica Scandinavica"},{"issue":"5","key":"10.1007\/s13311-019-00815-3_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrneurol.2016.45","article-title":"Nonconvulsive status epilepticus in adults - insights into the invisible","volume":"12","author":"Sutter","year":"2016","journal-title":"Nature Reviews Neurology"},{"issue":"8","key":"10.1007\/s13311-019-00815-3_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/archneurol.2010.169","article-title":"Frequency and Prognosis of Convulsive Status Epilepticus of Different Causes A Systematic Review","volume":"67","author":"Neligan","year":"2010","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1007\/s13311-019-00815-3_bib14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","article-title":"Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study","volume":"82","author":"Sutter","year":"2014","journal-title":"Neurology"},{"key":"10.1007\/s13311-019-00815-3_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.seizure.2016.12.001","article-title":"Prognosis of status epilepticus in patients requiring intravenous anesthetic drugs (a single center experience)","volume":"45","author":"Santamarina","year":"2017","journal-title":"Seizure"},{"issue":"2","key":"10.1007\/s13311-019-00815-3_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","article-title":"Refractory status epilepticus: a prospective observational study","volume":"51","author":"Novy","year":"2010","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-019-00815-3_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2015.04.047","article-title":"Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis","volume":"49","author":"Gorter","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1007\/s13311-019-00815-3_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/epi.12271","article-title":"A role for inflammation in status epilepticus is revealed by a review of current therapeutic approaches","volume":"54","author":"Janigro","year":"2013","journal-title":"Epilepsia"},{"issue":"11","key":"10.1007\/s13311-019-00815-3_bib19","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-019-00815-3_bib20","doi-asserted-by":"crossref","unstructured":"Wang, Y. and Z. Chen, An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy. Pharmacol Ther, 2019.","DOI":"10.1016\/j.pharmthera.2019.05.010"},{"issue":"4","key":"10.1007\/s13311-019-00815-3_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1007\/s13311-019-00815-3_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbi.2017.10.008","article-title":"High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy","volume":"72","author":"Ravizza","year":"2018","journal-title":"Brain Behavior and Immunity"},{"key":"10.1007\/s13311-019-00815-3_bib23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/brain\/awr032","article-title":"Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development","volume":"134","author":"Zurolo","year":"2011","journal-title":"Brain"},{"issue":"6894","key":"10.1007\/s13311-019-00815-3_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"10.1007\/s13311-019-00815-3_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2013.03.006","article-title":"Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures","volume":"58","author":"Iori","year":"2013","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"10.1007\/s13311-019-00815-3_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nature Medicine"},{"key":"10.1007\/s13311-019-00815-3_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2017.02.002","article-title":"Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy","volume":"64","author":"Zhao","year":"2017","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1007\/s13311-019-00815-3_bib28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41598-017-01325-y","article-title":"Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice","volume":"7","author":"Fu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-019-00815-3_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2014.05.007","article-title":"Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction","volume":"85","author":"Okuma","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-019-00815-3_bib30","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/brain\/awx117","article-title":"Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy","volume":"140","author":"Pauletti","year":"2017","journal-title":"Brain"},{"issue":"14","key":"10.1007\/s13311-019-00815-3_bib31","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1096\/fj.07-8770com","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J"},{"key":"10.1007\/s13311-019-00815-3_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2015.11.014","article-title":"Low-frequency stimulation in anterior nucleus of thalamus alleviates kainate-induced chronic epilepsy and modulates the hippocampal EEG rhythm","volume":"276","author":"Wang","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-019-00815-3_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nbd.2018.06.006","article-title":"Pharmaco-genetic therapeutics targeting parvalbumin neurons attenuate temporal lobe epilepsy","volume":"117","author":"Wang","year":"2018","journal-title":"Neurobiology of Disease"},{"key":"10.1007\/s13311-019-00815-3_bib34","unstructured":"George Paxinos, K.B.J.F., The Mouse Brain in Stereotaxic Coordinates. Academic Press, 2001."},{"issue":"12","key":"10.1007\/s13311-019-00815-3_bib35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus","volume":"339","author":"Treiman","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1007\/s13311-019-00815-3_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0920-1211(90)90065-4","article-title":"A Progressive Sequence of Electroencephalographic Changes during Generalized Convulsive Status Epilepticus","volume":"5","author":"Treiman","year":"1990","journal-title":"Epilepsy Research"},{"key":"10.1007\/s13311-019-00815-3_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2016.04.036","article-title":"Interleukin-1 receptor is a target for adjunctive control of diazepam-refractory status epilepticus in mice","volume":"328","author":"Xu","year":"2016","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-019-00815-3_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nbd.2017.03.017","article-title":"Enhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus","volume":"103","author":"Joshi","year":"2017","journal-title":"Neurobiology of Disease"},{"issue":"10","key":"10.1007\/s13311-019-00815-3_bib39","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1528-1167.2005.00268.x","article-title":"Analysis of chronic seizure onsets after intrahippocampal kainic acid injection in freely moving rats","volume":"46","author":"Bragin","year":"2005","journal-title":"Epilepsia"},{"issue":"16","key":"10.1007\/s13311-019-00815-3_bib40","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1523\/JNEUROSCI.4786-14.2015","article-title":"Unit Activity of Hippocampal Interneurons before Spontaneous Seizures in an Animal Model of Temporal Lobe Epilepsy","volume":"35","author":"Toyoda","year":"2015","journal-title":"Journal of Neuroscience"},{"issue":"7","key":"10.1007\/s13311-019-00815-3_bib41","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2008.01706_3.x","article-title":"Controversial topics in epilepsy","volume":"49","author":"Shorvon","year":"2008","journal-title":"Epilepsia"},{"issue":"2","key":"10.1007\/s13311-019-00815-3_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.24986","article-title":"Timing Is Everything: Where Status Epilepticus Treatment Fails","volume":"82","author":"Hill","year":"2017","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1007\/s13311-019-00815-3_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00415-012-6644-x","article-title":"Treatment deviating from guidelines does not influence status epilepticus prognosis","volume":"260","author":"Rossetti","year":"2013","journal-title":"Journal of Neurology"},{"issue":"34","key":"10.1007\/s13311-019-00815-3_bib44","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"Journal of Neuroscience"},{"issue":"19","key":"10.1007\/s13311-019-00815-3_bib45","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABA(A) receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"Journal of Neuroscience"},{"key":"10.1007\/s13311-019-00815-3_bib46","first-page":"166","article-title":"Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment","volume":"1378","author":"Niquet","year":"2016","journal-title":"Countermeasures against Chemical Threats Ii"},{"issue":"5","key":"10.1007\/s13311-019-00815-3_bib47","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/STROKEAHA.110.598334","article-title":"Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood-Brain Barrier From Ischemia-Induced Disruption in Rats","volume":"42","author":"Zhang","year":"2011","journal-title":"Stroke"},{"issue":"12","key":"10.1007\/s13311-019-00815-3_bib48","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1089\/ars.2013.5349","article-title":"Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons","volume":"21","author":"Balosso","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"10.1007\/s13311-019-00815-3_bib49","doi-asserted-by":"crossref","first-page":"e44518","DOI":"10.1371\/journal.pone.0044518","article-title":"Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein","volume":"7","author":"Pedrazzi","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1007\/s13311-019-00815-3_bib50","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1159\/000460513","article-title":"Extracellular HMGB1 Modulates Glutamate Metabolism Associated with Kainic Acid-Induced Epilepsy-Like Hyperactivity in Primary Rat Neural Cells","volume":"41","author":"Kaneko","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"10.1007\/s13311-019-00815-3_bib51","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.74.9.3805","article-title":"Specific Benzodiazepine Receptors in Rat-Brain Characterized by High-Affinity [Diazepam-H-3] Binding - (Affinity Binding Diazepam Anxiolytic Activity Brain Membranes Regional Distribution)","volume":"74","author":"Braestrup","year":"1977","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1007\/s13311-019-00815-3_bib52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.23602","article-title":"Anti-high mobility group box-1 antibody therapy for traumatic brain injury","volume":"72","author":"Okuma","year":"2012","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1007\/s13311-019-00815-3_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The safety and side effects of monoclonal antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nature Reviews Drug Discovery"},{"issue":"10","key":"10.1007\/s13311-019-00815-3_bib54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3229","article-title":"Development trends for human monoclonal antibody therapeutics","volume":"9","author":"Nelson","year":"2010","journal-title":"Nature Reviews Drug Discovery"},{"issue":"11","key":"10.1007\/s13311-019-00815-3_bib55","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1167.2006.00817.x","article-title":"The blood-brain barrier and epilepsy","volume":"47","author":"Oby","year":"2006","journal-title":"Epilepsia"},{"issue":"4","key":"10.1007\/s13311-019-00815-3_bib56","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1528-1167.2007.00988.x","article-title":"Seizure-promoting effect of blood-brain barrier disruption","volume":"48","author":"Marchi","year":"2007","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-019-00815-3_bib57","doi-asserted-by":"crossref","unstructured":"Reznik, M.E., K. Berger, and J. Claassen, Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus. J Clin Med, 2016. 5(5).","DOI":"10.3390\/jcm5050054"},{"key":"10.1007\/s13311-019-00815-3_bib58","doi-asserted-by":"crossref","unstructured":"Rai, S. and F.W. Drislane, Treatment of Refractory and Super-refractory Status Epilepticus. Neurotherapeutics, 2018.","DOI":"10.1007\/s13311-018-0640-5"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00815-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-019-00815-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00815-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:57:56Z","timestamp":1761807476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923013697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1878747923013697"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00815-3","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00815-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}